T cell stemness and dysfunction in tumors are triggered by a common mechanism
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Stemness against adversity T lymphocytes are powerful immune cells that can destroy tumors, but cancers have developed tricks to evade killing. Vodnala et al. found that potassium ions in the tumor microenvironment serve a dual role of influencing T cell effector function and stemness (see the Perspective by Baixauli Celda et al. ). Increased potassium impairs T cell metabolism and nutrient uptake, resulting in a starvation state known as autophagy. The increased potassium can also preserve T cells in a stem-like state where they retain the capacity to divide. These seemingly divergent processes are linked to the cellular distribution of acetyl–coenzyme A, which, when manipulated, can restore the ability of human T cells to eliminate tumors in mice. Science , this issue p. eaau0135 ; see also p. 1395
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Disabled autophagy due to progressive depletion of spermidine in aging tissues 233 can be expected to interfere with the immune recognition of cancer cells due the incapacity of dendritic cells to recognize autophagy-deficient cancer cells, as well as due to defective T lymphocyte and NK cell responses.163,252”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [163]
Experimental — accuracy not yet measuredIn the citing paper
“This relies on cancer cell-autonomous effects but may also involve the autophagy-driven maintenance of a functional T cell memory stem cell pool, hence avoiding the exhaustion of the anticancer immune response.163”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [163]
In the citing paper
“In addition, the extracellular release of potassium by dying cancer cells leads to the induction of autophagy in CD8+ T cells, thus resulting in the acquisition of a stem cell‐like phenotype and ultimately improving tumor clearance.”
From Autophagy in major human diseases (2021) · cites this paper as Vodnala et al, 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
Trapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D. R., Pimentel, H., Salzberg, S. L., Rinn, J. L., & Pachter, L. (2012) · Nature Protocols · doi:10.1038/nprot.2012.016 · Cited by 12,116
Cancer immunotherapy using checkpoint blockade
Ribas, A., & Wolchok, J. D. (2018) · Science · doi:10.1126/science.aar4060 · Cited by 6,791
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894
Guidelines for the use and interpretation of assays for monitoring autophagy
Klionsky, D. J., Abdalla, F. C., Abeliovich, H., Abraham, R. T., Acevedo-Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P., Aguirre-Ghiso, J. A., et al. (2012) · Autophagy · doi:10.4161/auto.19496 · Cited by 4,330
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Dudley, M. E., Wunderlich, J. R., Robbins, P. F., Yang, J. C., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Sherry, R., Restifo, N. P., Hubicki, A. M., et al. (2002) · Science · doi:10.1126/science.1076514 · Cited by 2,823 · cited 2×
“For example, TILs can be expanded ex vivo (>10(10) cells) and readministered to cancer patients, resulting in clonal repopulation and the durable destruction of large metastatic solid tumors (2, 3).”
BackgroundSelf-citationAdoptive cell transfer as personalized immunotherapy for human cancer
Rosenberg, S. A., & Restifo, N. P. (2015) · Science · doi:10.1126/science.aaa4967 · Cited by 2,506 · cited 1×
“Nonetheless, the T cells of some patients maintain the capacity to proliferate, persist, and mediate the complete destruction of large tumor deposits (1).”
BackgroundSelf-citationRosenberg, S. A., Yang, J. C., Sherry, R. M., Kammula, U. S., Hughes, M. S., Phan, G. Q., Citrin, D. E., Restifo, N. P., Robbins, P. F., Wunderlich, J. R., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0116 · Cited by 2,140 · cited 1×
“For example, TILs can be expanded ex vivo (>10(10) cells) and readministered to cancer patients, resulting in clonal repopulation and the durable destruction of large metastatic solid tumors (2, 3).”
BackgroundSelf-citationDefining CD8+ T cells that provide the proliferative burst after PD-1 therapy
Im, S. J., Hashimoto, M., Gerner, M. Y., Lee, J., Kissick, H. T., Burger, M. C., Shan, Q., Hale, J. S., Lee, J., Nasti, T. H., et al. (2016) · Nature · doi:10.1038/nature19330 · Cited by 2,070 · cited 1×
“GSEA revealed that ↑[K]e conditioning resulted in a transcriptional profile that parallels the subset of CD8 T cells recently identified as retaining stemness and the capacity to respond to PD-1 therapy in the setting of chronic antigen exposure (15) (Fig.”
BackgroundDefining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Sade-Feldman, M., Yizhak, K., Bjorgaard, S. L., Ray, J. P., de Boer, C. G., Jenkins, R. W., Lieb, D. J., Chen, J. H., Frederick, D. T., Barzily-Rokni, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.038 · Cited by 2,053 · cited 6×
“We and others have previously identified the transcription factor Tcf7 as being critically involved in the retention of stemcell–like attributes in antigen-experienced T cells (9, 11).”
BackgroundInfluential
Research works printed but not linked: 1
- H. Lodish A. Berk S. Zipursky in Molecular Cell Biology 4th Edition (2000) pp. 1–5.
Cited by
Items 201–300 of 559
ACC1-expressing pathogenic T helper 2 cell populations facilitate lung and skin inflammation in mice
Nakajima, T., Kanno, T., Yokoyama, S., Sasamoto, S., Asou, H. K., Tumes, D. J., Ohara, O., Nakayama, T., & Endo, Y. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20210639 · Cited by 42
Development of tumor-evolution-targeted anticancer therapeutic nanomedicineEVT
Zhang, L., Yang, J., Huang, J., Yu, Y., Ding, J., Karges, J., & Xiao, H. (2024) · Chem · doi:10.1016/j.chempr.2023.12.019 · Cited by 39
Self-citationMetabolism in tumor-associated macrophages
Li, J., DeNicola, G. M., & Ruffell, B. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.01.004 · Cited by 39
Advances into understanding metabolites as signaling molecules in cancer progression
Liu, J. Y., & Wellen, K. E. (2020) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2020.01.013 · Cited by 39
Pistollato, F., Forbes-Hernández, T. Y., Iglesias, R. C., Ruíz, R., Elexpuru-Zabaleta, M., Azpíroz, I. D., Cianciosi, D., Quiles, J. L., Giampieri, F., & Battino, M. A. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.11.017 · Cited by 39
Hematopoietic versus Solid Cancers and T Cell Dysfunction: Looking for Similarities and Distinctions
Montironi, C., Muñoz‐Pinedo, C., & Eldering, E. (2021) · Cancers · doi:10.3390/cancers13020284 · Cited by 40
“Anergy is caused by insufficient co-stimulatory signals during priming; senescence is growth arrest after extensive proliferation; exhaustion is characterized by expression of inhibitory signals after an excessive activating signal due to chronic antigen stimulation [17].”
BackgroundNon-viral siRNA delivery to T cells: Challenges and opportunities in cancer immunotherapy
Hoeck, J. V., Braeckmans, K., Smedt, S. C. D., & Raemdonck, K. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121510 · Cited by 37
Caloric restriction for the immunometabolic control of human health
Procaccini, C., de Candia, P., Russo, C., Rosa, G. D., Lepore, M. T., Colamatteo, A., & Matarese, G. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad035 · Cited by 37
CAR‐T‐cell products in solid tumors: Progress, challenges, and strategies
Qian, K., Li, G., Zhang, S., Fu, W., Li, T., Zhao, J., Lei, C., Wang, Y., & Hu, S. (2024) · Interdisciplinary medicine · doi:10.1002/inmd.20230047 · Cited by 41
Duan, R., Jiang, L., Wang, T., Li, Z., Yu, X., Gao, Y., Jia, R., Fan, X., & Su, W. (2024) · Nature Communications · doi:10.1038/s41467-024-55164-3 · Cited by 39
“This stemness phenotype enables CD8+ T cells to effectively eradicate large metastatic tumors 67 .”
Cell-Membrane-Anchored DNA Logic-Gated Nanoassemblies for In Situ Extracellular Bioimaging
Gong, H., Dai, Q., & Peng, P. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c13735 · Cited by 37
Chen, C.-Y., Ueha, S., Ishiwata, Y., Shichino, S., Yokochi, S., Yang, D., Oppenheim, J. J., Ogiwara, H., Deshimaru, S., Kanno, Y., et al. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0265 · Cited by 36
Chirra, M., Newton, H. S., Gawali, V. S., Wise-Draper, T. M., Chimote, A. A., & Conforti, L. (2022) · Cancers · doi:10.3390/cancers14153564 · Cited by 37
“They demonstrated that extracellular [K+] leads to T cell starvation and metabolic and epigenetic reprogramming that, while limiting T cell effector functions, promote stem cell-like programs [66].”
BackgroundGPR34 is a metabolic immune checkpoint for ILC1-mediated antitumor immunity
Yan, J., Zhang, C., Xu, Y., Huang, Z., Ye, Q., Qian, X., Zhu, L., Huang, G., Wang, X., Jiang, W., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01973-z · Cited by 35
Hickey, J. W., Agmon, E., Horowitz, N. B., Tan, T.-K., Lamore, M., Sunwoo, J. B., Covert, M. W., & Nolan, G. P. (2024) · Cell Systems · doi:10.1016/j.cels.2024.03.004 · Cited by 34
“27,63,64 Specifically, we transferred T cells that were treated or not with 2HC into B16F10 established tumors (day 10) and harvested them 3 days after treatment (day 13) for CODEX multiplexed imaging.”
InfluentialWu, H., Li, S., Zhou, M., Jiang, A., He, Y., Wang, S., Yang, W., & Liu, H. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01308 · Cited by 33
“In the current study, similar results also showed that the amount of IFN-γ CD8 TILs was at a low level at 8 days after RFA alone, which may be attributed to the persistence of in situ antigens and the elevated extracellular potassium (34, 36).”
ResultMichaels, M., & Madsen, K. L. (2023) · Mucosal Immunology · doi:10.1016/j.mucimm.2022.11.001 · Cited by 36
Autophagy in T‐cell differentiation, survival and memory
Wang, L., Das, J. K., Kumar, A., Peng, H., Ren, Y., Xiong, X., Yang, J., & Song, J. J. (2020) · Immunology and Cell Biology · doi:10.1111/imcb.12422 · Cited by 32
“On the one hand, Nicolas P Restifo and colleagues showed that the higher potassium concentration in the tumor microenvironment triggered caloric restriction and induced autophagic activity, improving the CD8 T cell persistence and stemness.(40) Although these results are divergent, they both suggest significant roles…”
BackgroundEriau, E., Paillet, J., Kroemer, G., & Pol, J. G. (2021) · Cancers · doi:10.3390/cancers13061260 · Cited by 33
“Yet, no combination with ER has been reported, despite recent reports [68] that tumor-infiltrating lymphocytes enter an autophagy-induced adaptive stem-like state which helps in maintaining their anti-tumor potential.”
BackgroundResultLiu, Z., Choksi, S., Kwon, H., Jiao, D., Liu, Z.-G., & Liu, Z.-G. (2023) · Breast Cancer Research · doi:10.1186/s13058-023-01604-9 · Cited by 33
Mog, B. J., Marcou, N., DiNapoli, S. R., Pearlman, A. H., Nichakawade, T. D., Hwang, M. S., Douglass, J., Hsiue, E. H.-C., Glavaris, S. A., Wright, K. M., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adg7123 · Cited by 32
Liang, J., Jin, X., Deng, X., Huang, Q., Zhang, S., Chen, W., & Zhang, X. (2024) · Materials Today · doi:10.1016/j.mattod.2024.07.004 · Cited by 32
Bridging epigenomics and tumor immunometabolism: molecular mechanisms and therapeutic implications
Xie, X., Liu, W. L., Yuan, Z., Chen, H.-Q., & Mao, W. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02269-y · Cited by 32
“Moreover, elevated extracellular potassium levels in the TME cause acetyl-CoA depletion and reduced histone acetylation in cytotoxic T cells, which changes their metabolic profile [140].”
Mitochondria and lysosomes in T cell immunometabolism
Norton, E. G., Chapman, N. M., & Chi, H. (2025) · Trends in Immunology · doi:10.1016/j.it.2025.07.014 · Cited by 33
“High levels of extracellular potassium in the TME perturb nutrient uptake by CD8 + T cells and induce a starvation-like state, resulting in elevated autophagy flux that is associated with increased T cell stemness but reduced effector function [54].”
T Cell Metabolism in Cancer Immunotherapy
Aksoylar, H., Tijaro-Ovalle, N. M., Boussiotis, V. A., & Patsoukis, N. (2020) · Immunometabolism · doi:10.20900/immunometab20200020 · Cited by 32
“These observations suggest that pharmacologic intervention to induce generation of such Th1/Th17 hybrid T cells might represent a highly promising approach for improvement of ACT.”
BackgroundInfluentialIon Channels in Cancer: Orchestrators of Electrical Signaling and Cellular Crosstalk
Fan, J. J., & Huang, X. (2020) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2020_48 · Cited by 32
“These altered T cells display increased stemness and improved persistence in vivo (Vodnala et al. 2019).”
BackgroundIsobacachalcone induces autophagy and improves the outcome of immunogenic chemotherapy
Wu, Q., Tian, A.-L., Durand, S., Aprahamian, F., Nirmalathasan, N., Xie, W., Liu, P., Zhao, L., Zhang, S., Pan, H., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03226-x · Cited by 31
del Rosario, R. C. H., Poschmann, J., Lim, C., Cheng, C. Y., Kumar, P., Riou, C., Ong, S. T., Gerges, S., Hajan, H. S., Kumar, D., et al. (2022) · Nature Microbiology · doi:10.1038/s41564-021-01049-w · Cited by 31
Focusing on CD8+ T-cell phenotypes: improving solid tumor therapy
Yao, Z., Zeng, Y., Liu, C., Jin, H., Wang, H., Zhang, Y., Ding, C., Chen, G., & Wu, D. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03195-5 · Cited by 33
“On the other hand, high extracellular K + levels also inhibit T cell effector programs by limiting the uptake of nutrients, thereby inducing T cell autophagy, reducing the expression of exhaustion programs, and inducing CD8 + T cell stemness transformation and effector function inhibition [334].”
BackgroundAutophagy in the Immunosuppressive Perivascular Microenvironment of Glioblastoma
Molina, M. L., García‐Bernal, D., Martínez, S., & Valdor, R. (2019) · Cancers · doi:10.3390/cancers12010102 · Cited by 31
Epigenetics of T cell fate decision.
Pace, L., & Amigorena, S. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.01.002 · Cited by 22
Metal-Based Nanoparticles for Cancer Metalloimmunotherapy
Suliman, I. H., Kim, K. H., Chen, W., Kim, Y., Moon, J. H., Son, S., & Nam, J. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15072003 · Cited by 33
Regulation of anti-tumor immunity by metal ion in the tumor microenvironment
Gao, Y., Liu, S., Huang, Y., Li, F., & Zhang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1379365 · Cited by 29
“Hexokinase II also requires K + as a cofactor to mediate anti-tumor immunity (137).”
BackgroundGBM immunotherapy: Exploring molecular and clinical frontiers
Ghosh, M. K., Kumar, S., Begam, S., Ghosh, S., & Basu, M. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123018 · Cited by 30
TIL Therapy in Lung Cancer: Current Progress and Perspectives
Hu, W., Bian, Y., & Ji, H. (2024) · Advanced Science · doi:10.1002/advs.202409356 · Cited by 31
Metabolic immunoengineering approaches to enhance CD8+ T cell-based cancer immunotherapy
Feng, B., Li, R., Li, W., & Tang, L. (2024) · Cell Systems · doi:10.1016/j.cels.2024.11.010 · Cited by 29
Addressing Patient to Patient Variability for Autologous CAR T Therapies
Jiang, J., & Ahuja, S. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.12.015 · Cited by 31
L-type amino acid transporter 1 as a target for inflammatory disease and cancer immunotherapy
Hayashi, K., & Anzai, N. (2021) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2021.09.006 · Cited by 30
Kishton, R. J., Vodnala, S. K., Vizcardo, R., & Restifo, N. P. (2021) · Current Opinion in Immunology · doi:10.1016/j.coi.2021.10.001 · Cited by 29
Self-citationInteractions of Autophagy and the Immune System in Health and Diseases
Pant, A., Yao, X., Lavedrine, A., Viret, C., Dockterman, J., Chauhan, S. C., Shi, C.-S., Manjithaya, R. R., Cadwell, K., Kufer, T. A., et al. (2022) · Autophagy Reports · doi:10.1080/27694127.2022.2119743 · Cited by 32
Levite, M. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.357903 · Cited by 29
Tumor interstitial fluid analysis enables the study of microenvironment–cell interactions in cancers
Saab, J. J. A., & Muir, A. (2023) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2023.102970 · Cited by 32
Zuo, Z., Yin, H., Zhang, Y., Xie, C., & Wang, Q. (2023) · Nature Communications · doi:10.1038/s41467-023-41335-1 · Cited by 29
“14).”
Rao, M., Dodoo, E., Zumla, A. I., & Maeurer, M. J. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00962 · Cited by 30
ACC1 is a dual metabolic-epigenetic regulator of Treg stability and immune tolerance
Stüve, P., Godoy, G. J., Ferreyra, F. N., Hellriegel, F., Boukhallouk, F., Kao, Y.-S., More, T. H., Matthies, A.-M., Akimova, T., Abraham, W., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102111 · Cited by 28
Current Advances and Challenges in CAR-T Therapy for Hematological and Solid Tumors
Zhang, G., Bai, M., Du, H., Yuan, Y., Wang, Y., Fan, W., Zhu, H., Wu, D., He, P., & Xue, B. (2025) · ImmunoTargets and Therapy · doi:10.2147/itt.s519616 · Cited by 29
“188 Furthermore, SOCE-inhibitor BTP-2 reduces intracellular calcium signaling via SOCE-Calcineurin-NFAT pathway, resulting in higher proliferation and lower exhaustion signals.”
Metabolic Control of Memory T-Cell Generation and Stemness
Raynor, J. L., Chapman, N. M., & Chi, H. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a037770 · Cited by 29
“…Leong et al. 2016; Wu et al. 2016); CD8+ progenitor-exhausted (Paley et al. 2012); CD8+ TME-associated stem-cell-like (Wu et al. 2016; Kurtulus et al. 2019; Miller et al. 2019; Siddiqui et al. 2019; Vodnala et al. 2019); human CD8+ stem-cell-like (Turtle et al. 2009; Gattinoni et al. 2011) cells.”
BackgroundInfluentialTumour interstitial fluid-enriched phosphoethanolamine suppresses T cell function
Wang, Y., Wilfahrt, D. N., Jonker, P. B., Lontos, K., Cai, C., Cameron, B., Xie, B., Peralta, R. M., Schoedel, E. R., Gunn, W. G., et al. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01650-9 · Cited by 29
Nanotechnologies for enhancing cancer immunotherapy
Yang, J., Wang, C., Shi, S., & Dong, C. (2020) · Nano Research · doi:10.1007/s12274-020-2904-8 · Cited by 27
You, D., Zhang, M., He, W., Wang, D., Yu, Y., Yu, Z., Lange, T., Yang, S., Wei, Y., Ma, H., et al. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-870 · Cited by 27
“This can cause a profound suppression of T-cells effector function (21,22).”
BackgroundSelf-citationPotassium shapes antitumor immunity
Baixauli, F., Villa, M., & Pearce, E. L. (2019) · Science · doi:10.1126/science.aaw8800 · Cited by 27
Raynor, J. L., Collins, N., Shi, H., Guy, C. S., Saravia, J., Lim, S. A., Chapman, N. M., Zhou, P., Wang, Y., Sun, Y., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.09.013 · Cited by 26
Aria, H., Rezaei, M., Nazem, S., Daraei, A., Nikfar, G., Mansoori, B., Bahmanyar, M., Tavassoli, A., Vakil, M. K., & Mansoori, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.947885 · Cited by 26
“Furthermore, K is released through P2XR into the TME by necrotizing tumors, causing effector T cell suppression via autophagy and caloric limitation, which drive epigenetic and metabolic reprogramming (8, 63, 64).”
BackgroundThe Paradoxical Roles of Inflammation during PD-1 Blockade in Cancer
Hill, M., Segovia, M., Russo, S., Girotti, M. R., & Rabinovich, G. A. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.09.003 · Cited by 27
Quantifiable blood TCR repertoire components associate with immune aging
Hu, J. R., Pan, M., Reid, B. M., Tworoger, S. S., & Li, B. (2024) · Nature Communications · doi:10.1038/s41467-024-52522-z · Cited by 25
“Particularly, putative T cell stemness markers TCF7 , BACH2 and KLF2 35 – 37 were signi fi cantly down-regulated in the eRFU group (Fig.”
BackgroundShort-chain fatty acids in the tumor microenvironment: from molecular mechanisms to cancer therapy
Xiang, Y., Du, A., Wang, Z., Pan, H., & Yuan, K. (2025) · Theranostics · doi:10.7150/thno.119304 · Cited by 27
“In addition, upregulating ACSS1 expression in CD8 + T cells improves their acetate metabolic capacity, thereby boosting antitumor activity [60].”
Shandell, M. A., Capatina, A. L., Lawrence, S. M., Brackenbury, W. J., & Lagos, D. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101707 · Cited by 27
Giansanti, M., Theinert, T., Boeing, S. K., Haas, D., Schlegel, P., Vacca, P., Nazio, F., & Caruana, I. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01893-w · Cited by 27
“Con-trarily, Vodnala et al . reported that, upon starvation conditions, CD8 + T cells undergo changes in histone acetylation showing less exhaustion and leading to an improved tumor control [43].”
BackgroundThe Killer’s Web: Interconnection between Inflammation, Epigenetics and Nutrition in Cancer
Mecca, M., Picerno, S., & Cortellino, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052750 · Cited by 31
“Concurrently, a reduction in methionine and its derivatives impacts histone methylation and DNA methylation, resulting in the reorganization of chromatin and DNA [211–213] (Figure 3).”
BackgroundSong, G., Jiang, D., Wang, L., Ning, J., Sun, X., Su, F., Chen, M., & Tian, Y. (2020) · Chemical Communications · doi:10.1039/d0cc00579g · Cited by 25
Dietary Regulation of Memory T Cells
Collins, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124363 · Cited by 26
“Furthermore, melanoma-specific CD8+ T cells cultured in vitro under conditions that induce ‘functional caloric restriction’ showed reduced mTOR signaling and mediated striking tumor control following adoptive transfer into mice [51].”
BackgroundTargeting metabolism to improve CAR-T cells therapeutic efficacy
Liu, S., Zhao, Y., Gao, Y., Li, F., & Zhang, Y. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003046 · Cited by 25
Liu, K., Li, Y., Shen, M., Xu, W., Wu, S., Yang, X., Zhang, B., & Lin, N. (2025) · Biomolecules · doi:10.3390/biom15010071 · Cited by 28
“The fluctuations in cellular acetyl-CoA levels, the main substrate for histone acetyltransferases, influence histone acetylation, which in turn impact TIL exhaustion [145,146].”
Aging-related genes are potential prognostic biomarkers for patients with gliomas
Xiao, G., Zhang, X., Zhang, X., Chen, Y., Xia, Z., Cao, H., Huang, J. X., & Cheng, Q. (2021) · Aging · doi:10.18632/aging.203008 · Cited by 31
“Cathepsin C (CTSC) is a lysosomal cysteine protease [47] and a member of aging-related genes.”
BackgroundSelf-citationA K+-sensitive AND-gate dual-mode probe for simultaneous tumor imaging and malignancy identification
Wang, Q., Li, F., Liang, Z., Liao, H., Zhang, B., Lin, P., Liu, X., Hu, S., Lee, J., & Ling, D. (2022) · National Science Review · doi:10.1093/nsr/nwac080 · Cited by 24
“Considering that necrotic cell death and overexpressed potassium ion (K+) channels aremajor hallmarks of malignant tumors [26–29], but not benign ones, the extracellular K+ concentration ([K+]ex) is significantly elevated in the malignant tumor microenvironment (∼40 mM) compared to that of benign tissue (∼5 mM) [30,31…”
BackgroundSelf-citationSugiyarto, G., Lau, D., Hill, S. L., Arcia, D., Boulanger, D. S. M., Parkes, E. E., James, E., & Elliott, T. J. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007114 · Cited by 24
Lei, X., Xiao, R., Chen, Z., Ren, J., Zhao, W., Tang, W., Wen, K., Zhu, Y., Li, X., Ouyang, S., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2412120121 · Cited by 25
In vivo photoacoustic potassium imaging of the tumor microenvironment
Tan, J. W. Y., Folz, J., Kopelman, R., & Wang, X. (2020) · Biomedical Optics Express · doi:10.1364/boe.393370 · Cited by 24
Early-phenotype CAR-T cells for the treatment of pediatric cancers
Meyran, D., Terry, R. L., Zhu, J. J., Haber, M., Ziegler, D. S., Ekert, P. G., Trapani, J. A., Darcy, P. K., & Neeson, P. J. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.07.018 · Cited by 24
Bioactive metallic nanoparticles for synergistic cancer immunotherapy
Wang, L., Lin, D., Li, M., Yu, J., Yang, Y., Wang, H., Chu, H., Ye, J., & Liu, Y. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.02.022 · Cited by 25
“…block T-cell function in cancer immunotherapy Recently, it has been shown that increasing the concentration of K in the TME promotes the persistence and stemness of tumor-infiltrating lymphocytes (TILs) through functional caloric restriction, which promotes autophagy and metabolic reprogramming 47 .”
Wilkens, A. B., Fulton, E. C., Pont, M. J., Cole, G. O., Leung, I., Stull, S. M., Hart, M. R., Bernstein, I. D., Furlan, S. N., & Riddell, S. R. (2022) · Blood · doi:10.1182/blood.2021015144 · Cited by 24
Du, Y., Wang, Q., Shi, L., & Li, T. (2022) · Nano Letters · doi:10.1021/acs.nanolett.2c02064 · Cited by 23
Engineered metal and their complexes for nanomedicine-elicited cancer immunotherapy
Wang, Y., Wang, B., Li, K., Wang, M., & Xiao, H. (2022) · Materials Today Advances · doi:10.1016/j.mtadv.2022.100276 · Cited by 28
Jo, J., Folz, J., Gonzalez, M. E., Paolì, A., Eido, A., Salfi, E., Tekula, S. R., Andò, S., Caruso, R., Kleer, C. G., et al. (2023) · ACS Nano · doi:10.1021/acsnano.2c09502 · Cited by 23
Effects of Obesity and Calorie Restriction on Cancer Development
Sergeeva, E. Y., Ruksha, T. G., & Fefelova, Y. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119601 · Cited by 24
Wan, X., Perry, J. A., Zhang, H., Feng, J., Ryan, K. A., Hout, C. V. V., Reid, J. G., Overton, J. D., Baras, A., Han, Z., et al. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020071030 · Cited by 23
Levite, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.617658 · Cited by 25
“T cell stemness combines the ability of a T cell to perpetuate its lineage and give rise to differentiated cells, and to interact with its environment to maintain a balance between quiescence, proliferation, and regeneration (4, 19).”
BackgroundHighly Selective Detection of K+ Based on a Dimerized G-Quadruplex DNAzyme
Cheng, Y., Cheng, M., Hao, J., Miao, W., Zhou, W., Jia, G., & Li, C. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c00872 · Cited by 23
Napiórkowska-Baran, K., Treichel, P., Dardzińska, A., Majcherczak, A., Pilichowicz, A., Szota, M., Szymczak, B., Alska, E., Przybyszewska, J., & Bartuzi, Z. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47020089 · Cited by 26
“High potassium concentrations in the tumor microenvironment can suppress effector T cell function and promote autophagy while maintaining stem-cell-like properties, resulting in CD8 + T cells with enhanced survival, multipotency, and anti-tumor abilities [38,39].”
Manganese-Driven Plasmid Nanofibers Formed In Situ for Cancer Gene Delivery and Metalloimmunotherapy
Li, J., Yang, R., Zhang, C., Lovell, J. F., & Zhang, Y. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.4c18511 · Cited by 22
Metallic nanomedicine in cancer immunotherapy
Li, S., Wang, X., Han, H., Xiang, S., Li, M., Long, G., Xia, Y., Zhang, Q., & Li, S. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.07.017 · Cited by 22
“For example, potassium (K + ), calcium (Ca 2 + ), and magnesium (Mg 2 + ) are responsible for the stemness and cytotoxic functions of T and NK cells 17-19 .”
InfluentialPresetting CAR-T cells during ex vivo biomanufacturing
Wang, X., Liao, Y., Liu, D., Zheng, J., & Shi, M. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.02.031 · Cited by 23
Wang, C., Han, L., Zhang, J., Ji, Q., Guo, X., Li, Y., Li, S., He, J., He, F., Dai, W., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217935 · Cited by 22
The role of small molecules in cell and gene therapy.
Brayshaw, L. L., Martínez-Fleites, C., Athanasopoulos, T., Southgate, T., Jespers, L., & Herring, C. (2021) · RSC Medicinal Chemistry · doi:10.1039/d0md00221f · Cited by 14
Conde, E., Casares, N., Mancheño, U., Elizalde, E., Vercher, E., Capozzi, R., Santamaría, E., Rodríguez-Madoz, J. R., Prósper, F., Lasarte, J. J., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.08.017 · Cited by 21
Schulz-Kuhnt, A., Rühle, K., Javidmehr, A., Döbrönti, M., Biwank, J., Knittel, S., Neidlinger, P., Leupold, J., Liu, L.-J., Dedden, M., et al. (2024) · Gut · doi:10.1136/gutjnl-2023-330543 · Cited by 25
“12 However, our data were not able to detect significantly altered mRNA expression levels of various autophagy-relevant genes in stimulated LPMCs in the absence of ACLY (online supplemental figure 6).”
BackgroundVilela, T., Valente, S., Correia, J., & Ferreira, F. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189144 · Cited by 21
Immunotherapy for Cutaneous T-Cell Lymphoma: Current Landscape and Future Developments
Sivanand, A., Surmanowicz, P., Alhusayen, R. O., Hull, P. R., Litvinov, I. V., Zhou, Y., & Gniadecki, R. (2019) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/1203475419867610 · Cited by 21
Industrializing engineered autologous T cells as medicines for solid tumours
Britten, C. M., Shalabi, A. M., & Hoos, A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00175-8 · Cited by 21
Metabolic Regulation of CD8 + T Cells: From Mechanism to Therapy
Zheng, Y. Y., Wang, X., & Huang, M. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0040 · Cited by 20
“Culturing with a high level of K + similarly elevated the expression of CD62L, a phenotypic marker of stemness, in tumor-infiltrating T cells obtained from patients with various types of cancer, including melanoma, colon cancer, lung cancer, and ovarian cancer (131).”
InfluentialNuclear Acly protects the liver from ischemia-reperfusion injury
Gao, W., Zhang, L., Li, Z., Wu, T., Lang, C., Mulholland, M. W., & Zhang, W. (2023) · Hepatology · doi:10.1097/hep.0000000000000692 · Cited by 20
“[22] Briefly, liver tissues were weighted and homogenized with 1% Triton-X-100, 20 mM Tris-HCL, 150 mM NaCl, and pH = 7.4 for 10 minutes.”
InfluentialSynergistic combination of oncolytic virotherapy with CAR T-cell therapy
Ajina, A., & Maher, J. F. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.06.015 · Cited by 21
Metabolic and epigenetic orchestration of (CAR) T cell fate and function
Akbari, B., Hosseini, Z., Shahabinejad, P., Ghassemi, S., Mirzaei, H. R., & O’Connor, R. S. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215948 · Cited by 22
KCNQ potassium channels modulate Wnt activity in gastro-oesophageal adenocarcinomas
Shorthouse, D., Zhuang, L., Rahrmann, E. P., Kosmidou, C., Wickham-Rahrmann, K., Hall, M., Greenwood, B. M., Devonshire, G., Gilbertson, R. J., Fitzgerald, R. C., et al. (2023) · Life Science Alliance · doi:10.26508/lsa.202302124 · Cited by 19
Intracellular K+ Limits T-cell Exhaustion and Preserves Antitumor Function
Collier, C., Wucherer, K., McWhorter, M., Jenkins, C., Bartlett, A. Q., Roychoudhuri, R., & Eil, R. L. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0319 · Cited by 20
Self-citationIntrinsic and Extrinsic Determinants of T Cell Metabolism in Health and Disease
Munford, H., & Dimeloe, S. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00118 · Cited by 19
“pinpoint potassium as being important in global nutrient insufficiencies in T cells (Vodnala et al., 2019).”
BackgroundIonic Regulation of T-Cell Function and Anti-Tumour Immunity
Ginefra, P., Hope, H. C., Spagna, M., Zecchillo, A., & Vannini, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413668 · Cited by 20
“Consequently, T cells exposed t high [K+]e during in vitro expansion enhanced T-cell persistence and anti-tumour response upon adoptive cell transfer in a B16 melanoma mouse model [32].”
BackgroundInfluentialWang, B., Hu, J. R., Zhang, J., & Zhao, L. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108646 · Cited by 19
Ohya, S., Matsui, M., Kajikuri, J., Kito, H., & Endo, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158603 · Cited by 19
“K+-driven cancer immunotherapy with a focus on K+ homeostasis is a potential therapeutic strategy for cancer [9,10]; however, the mechanisms underlying intracellular K+-driven cytokine/chemokine regulation in tumor-infiltrating immunosuppressive cells such as TAMs have not yet been elucidated.”
BackgroundPace, L. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a037754 · Cited by 20
Metadata
- Authors
- Vodnala, S. K., Eil, R., Kishton, R. J., Sukumar, M., Yamamoto, T. N., Ha, N.-H., Lee, P.-H., Shin, M., Patel, S. J., Yu, Z., Palmer, D. C., Kruhlak, M. J., Liu, X., Locasale, J. W., Huang, J., Roychoudhuri, R., Finkel, T., Klebanoff, C. A., & Restifo, N. P.
- Affiliations
- National Institutes of Health (US)
- National Cancer Institute (US)
- Laboratory of Cancer Biology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
- Duke University (US)
- Babraham Institute (GB)
- University of Pittsburgh (US)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Vodnala, Suman Kumar
- Eil, Robert
- Restifo, Nicholas P.
- ORCID
- Vodnala, Suman Kumar
- Eil, Robert
- Kishton, Rigel J.
- Sukumar, Madhusudhanan
- Yamamoto, Tori N.
- Ha, Ngoc-Han
- Lee, Ping-Hsien
- Shin, MinHwa
- Patel, Shashank J.
- Yu, Zhiya
- Palmer, Douglas C.
- Kruhlak, Michael J.
- Liu, Xiaojing
- Locasale, Jason W.
- Huang, Jing
- Roychoudhuri, Rahul
- Finkel, Toren
- Klebanoff, Christopher A.
- Restifo, Nicholas P.
- Venue
- Science
- Published
- 2019-03-29
- Volume
- 363
- Issue
- 6434
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC8194369
- OpenAlex
- W2924300946
- Cited by
- 552
- References
- 49
- Citations by year
- 2026: 55 · 2025: 77 · 2024: 78 · 2023: 70 · 2022: 86 · 2021: 76 · 2020: 73 · 2019: 36
- FWCI
- 27.07
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- American Cancer Society (129832-RSG-16-214-01-TBE)
- National Cancer Institute (P30 CA008748)
- NIH Clinical Center
- Damon Runyon Cancer Research Foundation
- Parker Institute for Cancer Immunotherapy
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- T cell stemness, T cell dysfunction, tumor microenvironment, potassium ions, T cell metabolism, nutrient uptake, autophagy, acetyl-CoA, T cell exhaustion, antitumor immunity, tumor immune evasion
- MeSH terms
- Acetyl Coenzyme A, Acetylation, Animals, Autophagy, Cell Differentiation, Histones, Humans, Immune Tolerance, Lymphocyte Activation, Mice, Inbred C57BL, Neoplasms, Potassium, Stem Cells, Lymphocytes, Tumor-Infiltrating, CD8-Positive T-Lymphocytes, Caloric Restriction, Epigenesis, Genetic, Mice, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.